ReCode Therapeutics Competitors and Similar CompaniesClear all

ReCode Therapeutics's competitors and similar companies include Vertex Pharmaceuticals and BillionToOne.
ReCode Therapeutics
ReCode Therapeutics
ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.
BillionToOne
BillionToOne
BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options.
Founding Date
Founding Date
2015
Founding Date
1989
Founding Date
2016
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Menlo Park, US HQ
Locations
Boston, US HQ
St Leonards, AU
Wien, AT
Bruxelles, BE
São Paulo, BR
Toronto, CA
Praha, CZ
see more
Locations
Menlo Park, US HQ
Employees
Employees
1062% decrease
Employees
5,40013% increase
Employees
620

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$12b (FY, 2025)
Revenue (est.)
$305.1m (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
$1.7b (FY, 2025)
Cost of goods
$96.7m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
$10.4b (FY, 2025)
Gross profit
$208.5m (FY, 2025)

Operating

Products
Products
N/A
Products
6 (FY, 2022)
Products
3 (Feb, 2023)

Funding

Total funding raised
Total funding raised
$ 82m
Total funding raised
$ 2.4m
Total funding raised
$ 87.5m
For sources of this data, please see the company profile

View Company Profiles

Vertex Pharmaceuticals
HQ
Boston, US
Employees
5,400↑ 13% increase

Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.

View company
BillionToOne
HQ
Menlo Park, US
Employees
620

BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options.

View company